F. Özkan

Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss.

I. Tezcan, Ayşe Ertoy, Deniz Çağdaş-Ayvaz, 2018, The Turkish journal of pediatrics.